Ivo Timmermans joined Clinigen Group in February 2016 as Chief Medical Officer, with global responsibility for regulatory issues, pharmacovigilance, medical affairs and product information.
Ivo has over twenty years of experience in the pharmaceutical industry. He has worked for Wellcome, GlaxoWellcome, BASF Pharma, Rhein Biotech and was in recent years an independent consultant. His previous roles have included positions as global medical director, global strategic advisor and CEO of start-up companies. Ivo graduated as Medical Doctor from the University of Nijmegen (Netherlands) and holds an MBA degree from Henley Management College (Henley-on-Thames, UK).